NEVPF

Neurovive Pharmaceutical AB

 
Ordinary Shares International Reporting
OTCQX International
Verified Company Profile 1/27/2017
Contact Info
  • Medicon Village
  • Scheelevagen 2
  • Lund 223 81
  • Sweden

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: OMX Nordic Exchange Stockholm
Audited Financials Audited
Latest Report Dec 31, 2016 Interim Financial Report
Fiscal Year End 12/31
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Sweden
Year of Inc. 2000
Employees 12 a/o Jun 01, 2016
Company Officers/Contacts
Erik Kinnman CEO
Catharina Jz Johansson CFO
Magnus Hansson CMO
Eskil Elmer CSO
Cecilia Hofvander Director, Inv. Rel.
Company Directors
Gregory Batcheller Executive Chairman
Service Providers
Accounting/Auditing Firm
Mazars
61 rue Henri Regnault
92075 Paris La Defense Cedex
France
 
Ernst & Young AB
Sweden
 
Securities Counsel

Not Available
Investor Relations Firm

Not Available
Company History
  • Sponsored for OTCQX by Citi on 06/02/2016
NEVPF Security Details
Share Structure
Market Value1 $31,885,988 a/o Mar 27, 2017
Authorized Shares 49,458,645 a/o Dec 30, 2015
Outstanding Shares 49,458,645 a/o Dec 30, 2015
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 17,248,125 a/o Dec 30, 2015
Par Value Not Available
Transfer Agent(s)
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
NVP - OMX Nordic Exchange Stockholm - Qualified
Short Selling Data
Short Interest 7,400 (4.23%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security